Literature DB >> 22936364

Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide.

Alberto García-Redondo1, Oriol Dols-Icardo, Ricard Rojas-García, Jesús Esteban-Pérez, Pilar Cordero-Vázquez, José Luis Muñoz-Blanco, Irene Catalina, Miguel González-Muñoz, Luis Varona, Esther Sarasola, Monica Povedano, Teresa Sevilla, Antonio Guerrero, Julio Pardo, Adolfo López de Munain, Celedonio Márquez-Infante, Francisco Javier Rodríguez de Rivera, Pau Pastor, Ivonne Jericó, Amaya Álvarez de Arcaya, Jesús S Mora, Jordi Clarimón, Juan Francisco Gonzalo-Martínez, Alexandra Juárez-Rufián, Gabriela Atencia, Rosario Jiménez-Bautista, Yolanda Morán, Javier Mascías, María Hernández-Barral, Solange Kapetanovic, María García-Barcina, Carmen Alcalá, Alvaro Vela, Concepción Ramírez-Ramos, Lucía Galán, Jordi Pérez-Tur, Beatriz Quintáns, M Jesús Sobrido, Roberto Fernández-Torrón, Juan José Poza, Ana Gorostidi, Carmen Paradas, Pablo Villoslada, Pilar Larrodé, José Luis Capablo, Jordi Pascual-Calvet, Miguel Goñi, Yolanda Morgado, Miriam Guitart, Sira Moreno-Laguna, Almudena Rueda, Carlos Martín-Estefanía, Carlos Cemillán, Rafael Blesa, Alberto Lleó.   

Abstract

A hexanucleotide repeat expansion in chromosome 9 open reading frame 72 (C9orf72) can cause amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD). We assessed its frequency in 781 sporadic ALS (sALS) and 155 familial ALS (fALS) cases, and in 248 Spanish controls. We tested the presence of the reported founder haplotype among mutation carriers and in 171 Ceph Europeans from Utah (CEU), 170 Yoruba Africans, 81 Han Chinese, and 85 Japanese subjects. The C9orf72 expansion was present in 27.1% of fALS and 3.2% of sALS. Mutation carriers showed lower age at onset (P = 0.04), shorter survival (P = 0.02), greater co-occurrence of FTD (P = 8.2 × 10(-5)), and more family history of ALS (P = 1.4 × 10(-20)), than noncarriers. No association between alleles within the normal range and the risk of ALS was found (P = 0.12). All 61 of the mutation carriers were tested and a patient carrying 28 hexanucleotide repeats presented with the founder haplotype. This haplotype was found in 5.6% Yoruba Africans, 8.9% CEU, 3.9% Japanese, and 1.6% Han Chinese chromosomes.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936364     DOI: 10.1002/humu.22211

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  36 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 2.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

3.  Prognostic models for amyotrophic lateral sclerosis: a systematic review.

Authors:  Lu Xu; Bingjie He; Yunjing Zhang; Lu Chen; Dongsheng Fan; Siyan Zhan; Shengfeng Wang
Journal:  J Neurol       Date:  2021-03-10       Impact factor: 4.849

Review 4.  The Genetics of C9orf72 Expansions.

Authors:  Ilse Gijselinck; Marc Cruts; Christine Van Broeckhoven
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

5.  Validation of a Long-Read PCR Assay for Sensitive Detection and Sizing of C9orf72 Hexanucleotide Repeat Expansions.

Authors:  EunRan Suh; Kaitlyn Grando; Vivianna M Van Deerlin
Journal:  J Mol Diagn       Date:  2018-08-20       Impact factor: 5.568

6.  Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.

Authors:  Tania F Gendron; Lillian M Daughrity; Michael G Heckman; Nancy N Diehl; Joanne Wuu; Timothy M Miller; Pau Pastor; John Q Trojanowski; Murray Grossman; James D Berry; William T Hu; Antonia Ratti; Michael Benatar; Vincenzo Silani; Jonathan D Glass; Mary Kay Floeter; Andreas Jeromin; Kevin B Boylan; Leonard Petrucelli
Journal:  Ann Neurol       Date:  2017-07       Impact factor: 10.422

7.  Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population.

Authors:  Mfon E Umoh; Christina Fournier; Yingjie Li; Meraida Polak; Latoya Shaw; John E Landers; William Hu; Marla Gearing; Jonathan D Glass
Journal:  Neurology       Date:  2016-08-03       Impact factor: 9.910

8.  ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family.

Authors:  Joanna Siuda; Tatiana Lewicka; Malgorzata Bujak; Grzegorz Opala; Aleksandra Golenia; Agnieszka Slowik; Marka van Blitterswijk; Matt Baker; Nilufer Ertekin-Taner; Zbigniew K Wszolek; Rosa Rademakers
Journal:  Eur Neurol       Date:  2014-05-24       Impact factor: 1.710

Review 9.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

10.  Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Janet Cady; Craig Zaidman; Paul Cooper; Taha Bali; Peggy Allred; Carlos Cruchaga; Michael Baughn; Ryan T Libby; Alan Pestronk; Alison Goate; John Ravits; Robert H Baloh
Journal:  Neurobiol Aging       Date:  2013-04-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.